PTC Therapeutics | PTCT - Capital Ordinaire





Capital Ordinaire Changement Date
Acadia Pharmaceuticals USD 172.31M 174K 2026-09
Alnylam Pharmaceuticals USD 133.88M 141K 2026-09
Amgen USD 541M 0 2026-09
BioCryst Pharmaceuticals USD 255.26M 42.2M 2026-06
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 193.54M 267K 2026-06
Cytokinetics USD 138.76M 14.33M 2026-06
Daiichi Sankyo JPY 1.82B 1.68M 2026-09
Enanta Pharmaceuticals USD 212K 1000 2023-12
Gilead Sciences USD 1.24B 1000K 2026-06
Incyte USD 200.98M 1.03M 2026-06
Ionis Pharmaceuticals USD 165.64M 265K 2026-06
Ironwood Pharmaceuticals USD 160K 0 2024-12
Karyopharm Therapeutics USD 22.54M 4.23M 2026-03
Novartis USD 1.89B 12.09M 2026-09
Pfizer USD 5.7B 0 2026-06
PTC Therapeutics USD 83.33M 445K 2026-06
Puma Biotechnology USD 5K 0 2024-06
Roche Holding CHF 796.77M 1.15M 2026-06
Sarepta Therapeutics USD 105.62M 53K 2026-06
TG Therapeutics USD 153.08M 2.23M 2026-06
Ultragenyx Pharmaceutical USD 98.6M 300K 2026-06
Vertex Pharmaceuticals USD 253.5M 200K 2026-09
Xencor USD 74.33M 265K 2026-06